Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
30.39
+0.92 (3.12%)
Jan 30, 2025, 4:00 PM EST - Market closed

Apellis Pharmaceuticals Employees

As of December 31, 2023, Apellis Pharmaceuticals had 706 total employees, including 702 full-time and 4 part-time employees. The number of employees decreased by 61 or -7.95% compared to the previous year.

Employees
706
Change (1Y)
-61
Growth (1Y)
-7.95%
Revenue / Employee
$1,013,054
Profits / Employee
-$354,251
Market Cap
3.78B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2023706-61-7.95%
Dec 31, 202276729161.13%
Dec 31, 202147610227.27%
Dec 31, 202037413959.15%
Dec 31, 2019235155193.75%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Related Stocks

Company Name Employees
UnitedHealth Group 440,000
Johnson & Johnson 131,900
Thermo Fisher Scientific 122,000
Abbott Laboratories 114,000
AstraZeneca 89,900
Novartis AG 76,057
Merck & Co. 72,000
Novo Nordisk 64,319
Employee Rankings